1-18 of 18
Authors: Patrick N. Harter
Journal Article
ACCEPTED MANUSCRIPT
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes Get access
Neuro-Oncology, noaf105, https://doi.org/10.1093/neuonc/noaf105
Published: 18 April 2025
Journal Article
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments Get access
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 77–88, https://doi.org/10.1093/neuonc/noae208
Published: 19 November 2024
Journal Article
PATH-12. CLINICAL AND NEUROPATHOLOGICAL MARKERS FOR DISTINGUISHING BETWEEN IDH-MUTANT ASTROCYTOMAS OF WHO GRADE 2 AND 3
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii180, https://doi.org/10.1093/neuonc/noae165.0711
Published: 11 November 2024
Journal Article
EXTH-13. COMBINED ANTI-ANGIOGENIC TREATMENT TO INCREASE INTRATUMORAL PERSISTENCE OF CAR T-CELLS IN LUNG CANCER BRAIN METASTASES
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii239, https://doi.org/10.1093/neuonc/noae165.0944
Published: 11 November 2024
Journal Article
EPEN-14. MOLECULAR MARKERS AND PREDICTORS OF OUTCOME FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA IN THE PROSPECTIVE, MULTICENTRE E-HIT2000 TRIAL AND SUBSEQUENT HIT-REGISTRIES: A POOLED ANALYSIS OF 244 PATIENTS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.216
Published: 18 June 2024
Journal Article
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2084–2099, https://doi.org/10.1093/neuonc/noae094
Published: 04 June 2024
Includes: Multimedia
Journal Article
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 503–513, https://doi.org/10.1093/neuonc/noad197
Published: 11 October 2023
Journal Article
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 2058–2071, https://doi.org/10.1093/neuonc/noad087
Published: 06 May 2023
Journal Article
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 315–325, https://doi.org/10.1093/neuonc/noac177
Published: 22 July 2022
Journal Article
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma
Neuro-Oncology, Volume 24, Issue 12, December 2022, Pages 2121–2132, https://doi.org/10.1093/neuonc/noac111
Published: 03 May 2022
Journal Article
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
Neuro-Oncology, Volume 24, Issue 2, February 2022, Pages 213–225, https://doi.org/10.1093/neuonc/noab159
Published: 03 July 2021
Journal Article
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 34–43, https://doi.org/10.1093/neuonc/noaa251
Published: 01 November 2020
Journal Article
Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma
Neuro-Oncology, Volume 21, Issue 3, March 2019, Pages 326–336, https://doi.org/10.1093/neuonc/noy184
Published: 10 November 2018
Journal Article
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
Neuro-Oncology, Volume 20, Issue 6, June 2018, Pages 743–752, https://doi.org/10.1093/neuonc/nox191
Published: 10 October 2017
Journal Article
The angiogenic switch leads to a metabolic shift in human glioblastoma
Neuro-Oncology, Volume 19, Issue 3, 1 March 2017, Pages 383–393, https://doi.org/10.1093/neuonc/now175
Published: 03 September 2016
Journal Article
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
Neuro-Oncology, Volume 18, Issue 12, 1 December 2016, Pages 1644–1655, https://doi.org/10.1093/neuonc/now113
Published: 10 June 2016
Journal Article
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas
Neuro-Oncology, Volume 18, Issue 2, February 2016, Pages 173–183, https://doi.org/10.1093/neuonc/nov288
Published: 30 November 2015
Journal Article
Melanoma brain metastasis is independent of lactate dehydrogenase A expression Get access
Neuro-Oncology, Volume 17, Issue 10, October 2015, Pages 1374–1385, https://doi.org/10.1093/neuonc/nov040
Published: 19 March 2015
